𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of SFRS13A in low-density lipoprotein receptor splicing

✍ Scribed by I-Fang Ling; Steven Estus

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
427 KB
Volume
31
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

Low-density lipoprotein receptor (LDLR) is a major apolipoprotein E (APOE) receptor and thereby is critical to cholesterol homeostasis and, possibly, Alzheimer disease (AD) development. We previously identified a single nucleotide polymorphism (SNP), rs688:C>T, that modulates LDLR exon 12 splicing and is associated with cholesterol levels in premenopausal women and with Alzheimer disease in men. To gain additional insights into LDLR splicing regulation, we seek to identify splicing factors that modulate LDLR splicing efficiency. By using an in vitro minigene study, we first found that ectopic expression of SFRS3 (SRp20), SFRS13A (SRp38), SFRS13A-2 (SRp38-2), and RBMX (hnRNP G) robustly decreased LDLR splicing efficiency. Although SFRS3 and SFRS13A specifically increased the LDLR transcript lacking exon 11, SFRS13A-2 and RBMX primarily increased the LDLR isoform lacking both exons 11 and 12. When we evaluated the relationship between the expression of these splicing factors and LDLR splicing in human brain and liver specimens, we found that overall SFRS13A expression was significantly associated with LDLR splicing efficiency in vivo. We interpret these results as suggesting that SFRS13A regulates LDLR splicing efficiency and may therefore emerge as a modulator of cholesterol homeostasis.

📜 SIMILAR VOLUMES

Very low density lipoprotein receptor in
Very low density lipoprotein receptor in Alzheimer disease
✍ Nicole Helbecque; Philippe Amouyel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

The apolipoprotein (APO) E4 isoform is associated with an accelerated rate of Alzheimer disease (AD) expression in sporadic as well as late-onset familial forms of the disease but the precise mechanism is unknown. In an attempt to approach the possible mechanisms involved, APOE receptors have been s

Role of the low-density lipoprotein rece
Role of the low-density lipoprotein receptor-related protein-1 in regulation of chondrocyte differentiation
✍ Kazumi Kawata; Satoshi Kubota; Takanori Eguchi; Norifumi H. Moritani; Tsuyoshi S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB

## Abstract The low‐density lipoprotein receptor‐related protein 1 (LRP1) is known as an endocytic and signal transmission receptor. We formerly reported the gene expression and the localization of LRP1 in cartilage tissue and chondrocytes, but its roles in the differentiation of chondrocytes remai

Spectrum of low density lipoprotein rece
Spectrum of low density lipoprotein receptor mutations in Czech hypercholesterolemic patients
✍ Viera Kuhrová; Hana Francová; Petra Zapletalová; Tomáš Freiberger; Lenka Fajkuso 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB

The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in Czech hypercholesterolemic individuals. A combination of heteroduplex analysis, SSCP, DGGE, DNA sequencing and PCR/restriction analysis was used for this purpose. Molecular searching in the promoter

Spectrum of low density lipoprotein rece
Spectrum of low density lipoprotein receptor mutations in Czech hypercholesterolemic patients
✍ Viera Kuhrová; Hana Francová; Petra Zapletalová; Tomáš Freiberger; Lenka Fajkuso 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB

The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in Czech hypercholesterolemic individuals. A combination of heteroduplex analysis, SSCP, DGGE, DNA sequencing and PCR/restriction analysis was used for this purpose. Molecular searching in the promoter